NLRP3 inhibitors

The present invention relates to novel compounds # imgabs0 # having the general formula Ib wherein R1, R2, R3, R4, R5 and Z are as described herein, compositions including the compounds, and methods of using the compounds. 本发明涉及具有所述通式Ib的新型化合物#imgabs0#其中R1、R2、R3、R4、R5和Z如本文所述，包括所述化合物的组成物以及使用所述化合物的方法。...

Full description

Saved in:
Bibliographic Details
Main Authors GUBA, WOLFGANG, JAESCHKE GEORG, MESCH, SCOTT, K, TOSTOV ALEXANDER MIKHAILOVICH, BUSH LAWRENCE A
Format Patent
LanguageChinese
English
Published 29.03.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention relates to novel compounds # imgabs0 # having the general formula Ib wherein R1, R2, R3, R4, R5 and Z are as described herein, compositions including the compounds, and methods of using the compounds. 本发明涉及具有所述通式Ib的新型化合物#imgabs0#其中R1、R2、R3、R4、R5和Z如本文所述，包括所述化合物的组成物以及使用所述化合物的方法。
AbstractList The present invention relates to novel compounds # imgabs0 # having the general formula Ib wherein R1, R2, R3, R4, R5 and Z are as described herein, compositions including the compounds, and methods of using the compounds. 本发明涉及具有所述通式Ib的新型化合物#imgabs0#其中R1、R2、R3、R4、R5和Z如本文所述，包括所述化合物的组成物以及使用所述化合物的方法。
Author JAESCHKE GEORG
TOSTOV ALEXANDER MIKHAILOVICH
GUBA, WOLFGANG
MESCH, SCOTT, K
BUSH LAWRENCE A
Author_xml – fullname: GUBA, WOLFGANG
– fullname: JAESCHKE GEORG
– fullname: MESCH, SCOTT, K
– fullname: TOSTOV ALEXANDER MIKHAILOVICH
– fullname: BUSH LAWRENCE A
BookMark eNrjYmDJy89L5WQQ8PMJCjBWyMzLyEzKLMkvKuZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoaG5uaWJpaGBo7GxKgBADiKII0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate NLRP3抑制剂
ExternalDocumentID CN117794910A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN117794910A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:54:52 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN117794910A3
Notes Application Number: CN202280033385
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240329&DB=EPODOC&CC=CN&NR=117794910A
ParticipantIDs epo_espacenet_CN117794910A
PublicationCentury 2000
PublicationDate 20240329
PublicationDateYYYYMMDD 2024-03-29
PublicationDate_xml – month: 03
  year: 2024
  text: 20240329
  day: 29
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies F. HOFFMANN-LA ROCHE AG
RelatedCompanies_xml – name: F. HOFFMANN-LA ROCHE AG
Score 3.6645827
Snippet The present invention relates to novel compounds # imgabs0 # having the general formula Ib wherein R1, R2, R3, R4, R5 and Z are as described herein,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title NLRP3 inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240329&DB=EPODOC&locale=&CC=CN&NR=117794910A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAZ0pZQ5MCrqpFmYGusD-V6KuZVqquW6imUWSiaG5salxGmi8w9fPzCPUxCvCNIKJIQu2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHoMPlgB1oFydb1wB_F39nNWdnW2c_Nb8gW9DcpKUJsG50ZGZgBTajzUG5wTXMCbQrpQC5SnETZGALAJqWVyLEwFSVIczA6Qy7eU2YgcMXOuENZELzXrEIg4CfT1CAsUJmXkZmUibojhxRBkU31xBnD12g0fFwf8Q7-yFcYSzGwALs36dKMCikgYTSQNdqm1oC60tglZ1mZpZqnJxkZmFgnmiRKMkghdscKXyS0gxcoDABLZkyspRhYCkpKk2VBdahJUlyYM8DAPhdcjs
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAZ0pZQ5MCrqpFmYGusD-V6KuZVqquW6imUWSiaG5salxGmi8w9fPzCPUxCvCNIKJIQu2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHoMPlgB1oFydb1wB_F39nNWdnW2c_Nb8gW9DcpKUJsG50ZGZgBTaxzUG5wTXMCbQrpQC5SnETZGALAJqWVyLEwFSVIczA6Qy7eU2YgcMXOuENZELzXrEIg4CfT1CAsUJmXkZmUibojhxRBkU31xBnD12g0fFwf8Q7-yFcYSzGwALs36dKMCikgYTSQNdqm1oC60tglZ1mZpZqnJxkZmFgnmiRKMkghdscKXyS8gycHiG-PvE-nn7e0gxcoPABLZ8yspRhYCkpKk2VBdanJUly4IAAAH2mdS4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NLRP3+inhibitors&rft.inventor=GUBA%2C+WOLFGANG&rft.inventor=JAESCHKE+GEORG&rft.inventor=MESCH%2C+SCOTT%2C+K&rft.inventor=TOSTOV+ALEXANDER+MIKHAILOVICH&rft.inventor=BUSH+LAWRENCE+A&rft.date=2024-03-29&rft.externalDBID=A&rft.externalDocID=CN117794910A